跳至主要内容
临床试验/IRCT2017060212789N15
IRCT2017060212789N15已完成3 期

The effect of Ceftazidime and Cloxacillin as an antibiotic lock solution for prevention of hemodialysis tunneled-catheter related blood stream infection in patients with chronic kidney disease

Vice Chancellor for Research of Kurdistan University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • patients with chronic kidney disease requiring dialysis with tunneled hemodialysis catheter. Exclusion criteria: changing vascular access to AVF; kidney transplant during the study; transferring patients to other centers; patients’ unwillingness to participate in the study; using Taurolock as lock solution; patients who were candidate for antibiotic prescription for reasons other than CRBSI.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research of Kurdistan University of Medical Sciences

相似试验